FI120537B - Trisubstituoituja fenyylijohdannaisia - Google Patents

Trisubstituoituja fenyylijohdannaisia Download PDF

Info

Publication number
FI120537B
FI120537B FI973440A FI973440A FI120537B FI 120537 B FI120537 B FI 120537B FI 973440 A FI973440 A FI 973440A FI 973440 A FI973440 A FI 973440A FI 120537 B FI120537 B FI 120537B
Authority
FI
Finland
Prior art keywords
formula
hydroxy
alkyl
compounds
carbon atoms
Prior art date
Application number
FI973440A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973440A (fi
FI973440A0 (fi
Inventor
Peter Nussbaumer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9505080.3A external-priority patent/GB9505080D0/en
Priority claimed from GBGB9505858.2A external-priority patent/GB9505858D0/en
Priority claimed from GBGB9526593.0A external-priority patent/GB9526593D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI973440A0 publication Critical patent/FI973440A0/fi
Publication of FI973440A publication Critical patent/FI973440A/fi
Application granted granted Critical
Publication of FI120537B publication Critical patent/FI120537B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/74Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
FI973440A 1995-03-14 1997-08-21 Trisubstituoituja fenyylijohdannaisia FI120537B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9505080 1995-03-14
GBGB9505080.3A GB9505080D0 (en) 1995-03-14 1995-03-14 Organic compounds
GB9505858 1995-03-23
GBGB9505858.2A GB9505858D0 (en) 1995-03-23 1995-03-23 Organic Compounds
GBGB9526593.0A GB9526593D0 (en) 1995-12-28 1995-12-28 Organic compounds
GB9526593 1995-12-28
PCT/EP1996/001116 WO1996028430A1 (en) 1995-03-14 1996-03-14 Trisubstituted phenyl derivatives
EP9601116 1996-03-14

Publications (3)

Publication Number Publication Date
FI973440A0 FI973440A0 (fi) 1997-08-21
FI973440A FI973440A (fi) 1997-10-24
FI120537B true FI120537B (fi) 2009-11-30

Family

ID=27267624

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973440A FI120537B (fi) 1995-03-14 1997-08-21 Trisubstituoituja fenyylijohdannaisia

Country Status (24)

Country Link
US (1) US5990116A (sk)
EP (1) EP0815087B1 (sk)
JP (1) JP3194963B2 (sk)
KR (1) KR100437580B1 (sk)
CN (1) CN1101386C (sk)
AT (1) ATE208763T1 (sk)
AU (1) AU704544B2 (sk)
BR (1) BR9607240A (sk)
CA (1) CA2214131C (sk)
CZ (1) CZ289944B6 (sk)
DE (1) DE69616993T2 (sk)
DK (1) DK0815087T3 (sk)
ES (1) ES2168463T3 (sk)
FI (1) FI120537B (sk)
HK (1) HK1014440A1 (sk)
HU (1) HUP9801828A3 (sk)
MX (1) MX9707022A (sk)
NO (1) NO310356B1 (sk)
NZ (1) NZ304291A (sk)
PL (1) PL185875B1 (sk)
PT (1) PT815087E (sk)
RU (1) RU2164224C2 (sk)
SK (1) SK282155B6 (sk)
WO (1) WO1996028430A1 (sk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747498A (en) 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
US6706721B1 (en) 1998-04-29 2004-03-16 Osi Pharmaceuticals, Inc. N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
JP3270834B2 (ja) 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
US7087613B2 (en) 1999-11-11 2006-08-08 Osi Pharmaceuticals, Inc. Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
JP4665331B2 (ja) * 2000-04-07 2011-04-06 チッソ株式会社 新規なジアミノ化合物、該ジアミノ化合物を用いて合成された重合体、並びに該重合体を用いたワニス、配向膜及び液晶表示素子
BR0213233A (pt) * 2001-10-12 2005-01-04 Warner Lambert Co Alcinos inibidores de metaloproteinase de matriz
US7053216B2 (en) 2001-11-19 2006-05-30 Iconix Pharmaceuticals, Inc. Modulators of Rho C activity
MXPA05000638A (es) * 2002-07-17 2005-03-31 Warner Lambert Co Combinacion de un inhibidor alquino alosterico de metaloproteinasa-13 de matriz con un inhibidor selectivo de ciclooxigenasa-2 que no es celecoxib o valdecoxib.
WO2004006914A1 (en) * 2002-07-17 2004-01-22 Warner-Lambert Company Llc Combination of an allosteric alkyne inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib
WO2004014384A2 (en) * 2002-08-13 2004-02-19 Warner-Lambert Company Llc Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
GB0319497D0 (en) * 2003-08-19 2003-09-17 Novartis Ag Organic compounds
SE0400234D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
US20080044439A1 (en) * 2004-03-11 2008-02-21 David Nathaniel E Compositions and Methods for Preventing and Treating Skin and Hair Conditions
US20080031898A1 (en) * 2004-03-26 2008-02-07 David Nathaniel E Compositions and methods to increase the effect of a neurotoxin treatment
GB0412769D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
RU2424232C2 (ru) * 2004-08-04 2011-07-20 Мейдзи Сейка Кайся, Лтд. Производные хинолина и инсектициды, включающие их в качестве активного ингредиента
WO2008044688A1 (fr) * 2006-10-11 2008-04-17 Daiichi Sankyo Company, Limited Dérivé de l'urée
AU2008213147A1 (en) * 2007-02-06 2008-08-14 Chelsea Therapeutics, Inc. New compounds, methods for their preparation and use thereof
AU2019232437A1 (en) 2018-03-07 2020-10-08 Bayer Aktiengesellschaft Identification and use of ERK5 inhibitors
WO2021026672A1 (en) * 2019-08-09 2021-02-18 Novartis Ag Heterocyclic wdr5 inhibitors as anti-cancer compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3066406D1 (en) * 1979-09-13 1984-03-08 Wellcome Found Diaryl compounds and pharmaceutical formulations containing them
CA1219587A (en) * 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
WO1988003800A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Lipoxygenase inhibitors
WO1988003806A1 (en) * 1986-11-19 1988-06-02 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
US5272167A (en) * 1986-12-10 1993-12-21 Schering Corporation Pharmaceutically active compounds
EP0407217A1 (en) * 1989-07-07 1991-01-09 Schering Corporation Pharmaceutically active compounds
HUT60458A (en) * 1991-02-01 1992-09-28 Sandoz Ag Process for producing benzyloxyphenyl derivatives and pharmaceutical compositions comprising same
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
US5409930A (en) * 1991-05-10 1995-04-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9121943D0 (en) * 1991-10-16 1991-11-27 Sandoz Ltd Organic compounds,processes for their production and their use
US5656643A (en) * 1993-11-08 1997-08-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Also Published As

Publication number Publication date
DE69616993T2 (de) 2002-07-04
HUP9801828A2 (hu) 1999-03-29
CA2214131C (en) 2009-06-23
DE69616993D1 (de) 2001-12-20
JP3194963B2 (ja) 2001-08-06
AU704544B2 (en) 1999-04-29
ATE208763T1 (de) 2001-11-15
MX9707022A (es) 1998-06-30
WO1996028430A1 (en) 1996-09-19
NO974118D0 (no) 1997-09-08
CZ289944B6 (cs) 2002-04-17
PT815087E (pt) 2002-04-29
KR100437580B1 (ko) 2004-07-16
FI973440A (fi) 1997-10-24
EP0815087B1 (en) 2001-11-14
DK0815087T3 (da) 2002-03-11
RU2164224C2 (ru) 2001-03-20
BR9607240A (pt) 1997-11-11
EP0815087A1 (en) 1998-01-07
SK282155B6 (sk) 2001-11-06
KR19980703049A (ko) 1998-09-05
ES2168463T3 (es) 2002-06-16
NZ304291A (en) 1999-01-28
AU5144396A (en) 1996-10-02
US5990116A (en) 1999-11-23
CN1183774A (zh) 1998-06-03
NO310356B1 (no) 2001-06-25
CN1101386C (zh) 2003-02-12
HK1014440A1 (en) 1999-09-30
FI973440A0 (fi) 1997-08-21
NO974118L (no) 1997-09-08
PL185875B1 (pl) 2003-08-29
PL322134A1 (en) 1998-01-05
SK124597A3 (en) 1998-01-14
CA2214131A1 (en) 1996-09-19
JPH11503412A (ja) 1999-03-26
HUP9801828A3 (en) 2001-02-28
CZ286997A3 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
FI120537B (fi) Trisubstituoituja fenyylijohdannaisia
CA2724077C (en) Amide compound
AP795A (en) Indazole derivatives.
ES2416289T3 (es) Nuevo derivado de 1,2-dihidroquinolina que tiene como sustituyentes un grupo alquilo inferior sustituido con fenilcalcógeno y un grupo fenilo introducido por un éster
EP3154954B1 (en) Metabotropic glutamate receptor negative allosteric modulators (nams) and uses thereof
JP4571863B2 (ja) 抗痛覚過敏剤として有用なキナゾリノン誘導体
EP0706795A2 (en) Catechol diether compounds as inhibitors of TNF release
JP2008527029A (ja) 炎症の治療に有用なインドール類
KR101503286B1 (ko) 벤즈이미다졸 trpv1 저해제
CZ218198A3 (cs) Nové cykloalkylem substituované imidazoly, způsob jejich přípravy, farmaceutické prostředky s jejich obsahem a způsob inhibice
EP1839655A1 (en) Ctgf expression inhibitor
AU2014366371A1 (en) Dimethylbenzoic acid compounds
KR20100016076A (ko) 신규 피롤리논 유도체 및 그것을 함유하는 의약 조성물
EP3585772B1 (en) 1, 4, 6-trisubstituted-2-alkyl-1h-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitors
US20040259869A1 (en) Cycloalkyl alkanoic acids as integrin receptor antagonists
EP3144303B1 (en) 6-substituted phenoxychroman carboxylic acid derivatives
WO2012012322A1 (en) Substituted hydroxamic acids and uses thereof
CA2888480A1 (en) Heteroaryl linked quinolinyl modulators of ror.gamma.t
Bai et al. Synthesis and biological evaluation of 4′-[(benzimidazole-1-yl) methyl] biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists
Lu et al. Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
CA2809287C (en) Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
JPH04210946A (ja) 新規なアリールビニルアミド誘導体およびその製造方法
WO2010073078A2 (en) Heterocyclic compounds as hdac inhibitors
JP2022511287A (ja) c-MYC標的剤としての置換複素環化合物
HRP20040260A2 (en) 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120537

Country of ref document: FI

MM Patent lapsed